Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -65.27% is 96% above its 5-year average of -1713.92%, near the high end of its 5-year range (-7814.34%–52.84%).
96.63% above its 12-month average of -1938.57%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2026 (2026-06-30): -1463.86%.
EBITDA MARGIN
-65.27%
EBITDA MARGIN AVG TTM
-1938.57%
EBITDA MARGIN AVG 3Y
-1411.11%
EBITDA MARGIN AVG 5Y
-1713.92%
EBITDA MARGIN AVG 10Y
-1378.00%
EBITDA MARGIN AVG 15Y
-2382.64%
EBITDA MARGIN AVG 20Y
-1098.92%
CURRENT VS TTM AVG
+96.63%
CURRENT VS 3Y AVG
+95.37%
CURRENT VS 5Y AVG
+96.19%
CURRENT VS 10Y AVG
+95.26%
CURRENT VS 15Y AVG
+97.26%
CURRENT VS 20Y AVG
+94.06%
Palatin Technologies, Inc.
Market Cap
$16.74M
EBITDA Margin
-65.27%
TTM Avg
-1938.57%
3Y Avg
-1411.11%
5Y Avg
-1713.92%
Market Cap
$16.82M
EBITDA Margin
-1287.62%
TTM Avg
-2964.71%
3Y Avg
-1700.58%
5Y Avg
-1592.26%
Market Cap
$16.84M
EBITDA Margin
-168.69%
TTM Avg
-262.41%
3Y Avg
-983.34%
5Y Avg
-3401.51%
Market Cap
$16.64M
EBITDA Margin
-82.81%
TTM Avg
-187.23%
3Y Avg
-342.47%
5Y Avg
-369.32%
Market Cap
$16.52M
EBITDA Margin
-579.88%
TTM Avg
-374.35%
3Y Avg
-344.55%
5Y Avg
-411.92%
Market Cap
$17.07M
EBITDA Margin
-30564.79%
TTM Avg
-16005.09%
3Y Avg
-14551.39%
5Y Avg
-13807.79%
Market Cap
$17.31M
EBITDA Margin
-521.61%
TTM Avg
-265.78%
3Y Avg
-984.51%
5Y Avg
-733.51%
Market Cap
$17.39M
EBITDA Margin
-23.24%
TTM Avg
-24.75%
3Y Avg
-25.93%
5Y Avg
-17.56%
Market Cap
$15.78M
EBITDA Margin
-13679.31%
TTM Avg
-8051.39%
3Y Avg
-4553.85%
5Y Avg
-5076.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palatin Technologies, Inc. (PTN) | $16.74M | -65.27% | -1938.57% | -1411.11% | -1713.92% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -1287.62% | -2964.71% | -1700.58% | -1592.26% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | -168.69% | -262.41% | -983.34% | -3401.51% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -82.81% | -187.23% | -342.47% | -369.32% |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -579.88% | -374.35% | -344.55% | -411.92% |
| PAVmed Inc. (PAVM)vs › | $17.07M | -30564.79% | -16005.09% | -14551.39% | -13807.79% |
| Lipocine Inc. (LPCN)vs › | $17.31M | -521.61% | -265.78% | -984.51% | -733.51% |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -23.24% | -24.75% | -25.93% | -17.56% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -13679.31% | -8051.39% | -4553.85% | -5076.49% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -14633.33% | -7486.14% | -4543.27% | -3157.51% |
Gross Margin
99.6%
EBITDA Margin
-65.3%
Operating Margin
-65.7%
Net Margin
-63.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -1463.86% |
| 2026-03-31 | -39.89% |
| 2025-12-31 | -6303.35% |
| 2025-09-30 | 52.84% |
| 2024-06-30 | -2330.21% |
| 2023-12-31 | -318.57% |
| 2023-09-30 | -281.72% |
| 2023-06-30 | -604.15% |
| 2023-03-31 | -596.24% |
| 2022-12-31 | -537.51% |
| 2022-09-30 | -999.60% |
| 2022-06-30 | -1682.57% |
| 2022-03-31 | -3557.22% |
| 2021-12-31 | -2587.54% |
| 2021-09-30 | -4459.26% |
| 2021-06-30 | -7814.34% |
| 2021-03-31 | -7193.30% |
| 2020-12-31 | 5634.71% |
| 2020-09-30 | 1362.62% |
| 2019-12-31 | -27282.16% |
| 2019-09-30 | -4974.69% |
| 2019-06-30 | 86.62% |
| 2019-03-31 | -16655.95% |
| 2018-09-30 | -16272.20% |
| 2018-06-30 | 59.57% |
| 2018-03-31 | -5.62% |
| 2017-12-31 | 27.85% |
| 2017-09-30 | 41.75% |
| 2017-06-30 | 42.27% |
| 2017-03-31 | -27.76% |
| 2016-09-30 | -114.82% |
| 2015-06-30 | 65.70% |
| 2015-03-31 | -176.20% |
| 2014-12-31 | 29.31% |
| 2014-09-30 | 18.68% |
| 2013-06-30 | 33109.45% |
| 2013-03-31 | -104997.43% |
| 2012-12-31 | -52073.87% |
| 2012-09-30 | -88624.70% |
| 2012-06-30 | -49665.14% |
| 2012-03-31 | -24131.08% |
| 2011-12-31 | -30066.45% |
| 2011-09-30 | -11432.36% |
| 2011-06-30 | -2768.16% |
| 2011-03-31 | -3825.13% |
| 2010-12-31 | -147.51% |
| 2010-09-30 | -1998.38% |
| 2010-06-30 | -585.75% |
| 2010-03-31 | -67.70% |
| 2009-12-31 | 52.04% |
| 2009-09-30 | 4.13% |
| 2009-06-30 | 3.15% |
| 2009-03-31 | 7.72% |
| 2008-12-31 | -201.71% |
| 2008-09-30 | -533.96% |
| 2008-06-30 | -490.36% |
| 2008-03-31 | -662.33% |
| 2007-12-31 | -676.74% |
| 2007-09-30 | -3.17% |
| 2007-06-30 | -232.06% |
| 2007-03-31 | -217.04% |
| 2006-12-31 | -190.16% |
| 2006-09-30 | -170.35% |
| 2006-06-30 | -159.00% |
| 2006-03-31 | -146.89% |
| 2005-12-31 | -174.74% |
| 2005-09-30 | -113.80% |
| 2005-06-30 | -83.27% |
| 2005-03-31 | -128.81% |
| 2004-12-31 | -59.54% |
| 2004-09-30 | -66.52% |
| 2004-06-30 | -65278.94% |
| 2004-03-31 | -4393.89% |
| 2003-12-31 | -1631.02% |
| 2003-09-30 | -362.43% |
| 2003-06-30 | -7750.74% |
| 2003-03-31 | -1680.70% |
| 2002-12-31 | -1929.07% |
| 2002-09-30 | -639.94% |
